Keyphrases
Down Syndrome
100%
Pulmonary Hypertension
64%
Children with Down Syndrome
55%
Pulmonary Hypertension in children
34%
Lung Development
27%
Childhood Lung Function
23%
Forced Expiratory Volume in 1 Second (FEV1)
19%
COVID-19
17%
Airway
17%
Lung
16%
Bronchopulmonary
15%
Anastomosis
15%
Bronchopulmonary Dysplasia
14%
Pediatric Pulmonary
14%
Clinical Characteristics
13%
Antiangiogenic Factors
13%
Lung Function
13%
Risk Factors
13%
Multidisciplinary Approach
13%
Pulmonary Medicine
11%
Pediatric Asthma
11%
Community-based Study
11%
Sleep-disordered Breathing
11%
Pregnancy Cohort Study
11%
Respiratory Disorders
11%
Child Sex
11%
Systemic-to-pulmonary Shunt
11%
Public Health Insurance
11%
Early-life Exposure
11%
Private Health Insurance
11%
Angiogenic
11%
COVID-19 Impact
11%
PM2.5 Exposure
11%
Maternal Cortisol
11%
Neonatal Airway
11%
Clinical Risk
11%
Sudden Infant Death
11%
Maternal-child
11%
Cardiovascular Complications
11%
New York City
11%
Prenatal Lead Exposure
11%
North America
11%
Vascular Growth
11%
Healthcare Utilization
11%
Multisystem Inflammatory Syndrome in children (MIS-C)
11%
Neonatal Onset
11%
Presenting Manifestation
11%
Interstitial Lung Disease
11%
Photosystem II
11%
Inflammatory Syndrome
11%
Medicine and Dentistry
Down Syndrome
69%
Pulmonary Hypertension
43%
Lung Development
30%
Pediatrics
28%
Disease
21%
Obstructive Sleep Apnea
16%
Surgical Anastomosis
15%
Cohort Analysis
15%
COVID-19
14%
Respiratory Disease
14%
Lung Dysplasia
14%
Neonatal Intensive Care Unit
14%
Childbirth
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Neonate
12%
Cardiovascular Disease
11%
Child Death
11%
Respiratory Medicine
11%
Asthma
11%
Pulmonary Shunt
11%
Hydrocortisone
11%
Study Heterogeneity
11%
Serositis
11%
Interstitial Lung Disease
11%
Hurler Syndrome
11%
Cortisol Awakening Response
9%
Cohort Effect
8%
Anatomy
7%
Clinician
5%
Silo-Filler's Disease
5%
Particular Matter 2.5
5%
Respiratory Physiology
5%
Propensity Score Matching
5%
Atmospheric Aerosol
5%
Persistent Truncus Arteriosus
5%
Neonatal Infant
5%
Persistent Fetal Circulation
5%
